Hepatitis C virus (HCV) causes chronic hepatitis, which can progress to cirrhosis and hepatocellular carcinoma. The World Health Organization estimates that approximately 2.35% of the world population (∼160 million individuals) is infected with HCV. Another widespread disorder, metabolic syndrome, comprises a group of correlated clinical features that have insulin resistance as a common pathogenic determinant; Continue reading →

The prognosis and management of patients with chronic viral hepatitis B and C depend on the amount and progression of liver fibrosis and the risk for cirrhosis. Liver biopsy, traditionally considered to be the reference standard for staging of fibrosis, has been challenged over the past decade by the development of noninvasive methodologies. These methods Continue reading →

However, breast cancer survival rates were best among 13 industrialized nations Read The Full Article…U.S. Health Care Spending High, But Quality Lags: Report Rid your body of weight and toxins. Not all colon cleansers are safe and effective. Read our recommendations BEFORE you buy!

Title: Fish Oil Doesn’t Cut Failure Rate of Hemodialysis GraftsCategory: Health NewsCreated: 5/1/2012 6:05:00 PMLast Editorial Review: 5/2/2012 12:00:00 AM Read The Full Article…Fish Oil Doesn’t Cut Failure Rate of Hemodialysis Grafts Rid your body of weight and toxins. Not all colon cleansers are safe and effective. Read our recommendations BEFORE you buy!

Title: Fish Oil Doesn’t Cut Failure Rate of Hemodialysis GraftsCategory: Health NewsCreated: 5/1/2012 6:05:00 PMLast Editorial Review: 5/2/2012 12:00:00 AM Read The Full Article…Fish Oil Doesn’t Cut Failure Rate of Hemodialysis Grafts Rid your body of weight and toxins. Not all colon cleansers are safe and effective. Read our recommendations BEFORE you buy!

The prognosis and management of patients with chronic viral hepatitis B and C depend on the amount and progression of liver fibrosis and the risk for cirrhosis. Liver biopsy, traditionally considered to be the reference standard for staging of fibrosis, has been challenged over the past decade by the development of noninvasive methodologies. These methods Continue reading →

Molecular biology techniques are routinely used to diagnose and monitor treatment of patients with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. These tools can detect and quantify viral genomes and analyze their sequence to determine their genotype or subtype and to identify nucleotide or amino acid substitutions associated with resistance to Continue reading →

Recently developed drugs and innovative strategies for the treatment of chronic infection with genotype 1 hepatitis C virus (HCV) have become the standard of care. The protease inhibitors telaprevir (Incivek) and boceprevir (Victrelis) are the first direct-acting antiviral (DAA) agents approved, and many more are being developed. These drugs substantially increased rates of sustained virologic Continue reading →

With the development of effective therapies against human immunodeficiency virus (HIV), hepatitis C virus (HCV) infection has become a major cause of morbidity and mortality among patients with both infections (coinfection). In addition to the high prevalence of chronic HCV, particularly among HIV-infected injection drug users, the rate of incident HIV infections is increasing among Continue reading →

New study found decrease in inflammation warning signals Read The Full Article…Healthy Weight Loss May Also Cut Your Cancer Risk Rid your body of weight and toxins. Not all colon cleansers are safe and effective. Read our recommendations BEFORE you buy!